T hrombin plays a central role in the mechanism of hemostasis, which determines the extent of a hemostatic plug or a thrombotic process 1 mainly in venous territories. The recent development of new tests based on the continuous registration of thrombin generation 2, 3 provides an overall assessment of coagulation potency. 4 Measurement of endogenous thrombin potential (ETP) in an individual is a more accurate index of a hypercoagulable phenotype than traditional coagulation tests that only reflect the initial formation of thrombin. Several studies have reported a relationship between ETP and the incidence of venous thromboembolism (VTE), [5] [6] [7] recurrent VTE, [8] [9] [10] and more recently of acute ischemic stroke. 11 Genetic control of ETP has been widely documented, 3 but environmental influences have received less study. Better knowledge of environmental contributors to ETP would improve our current understanding of the regulating processes leading to a procoagulant phenotype. It could also point us toward a new prevention strategy with fewer side effects than pharmacological treatments currently used.
Elevated ETP is associated with excessive body weight 12, 13 and with characteristics of metabolic syndrome (metS). 14 MetS associates central obesity, high blood pressure, insulin resistance, high glucose levels, and dyslipidemia. It exposes an individual to an increased prevalence of VTE. [15] [16] [17] [18] [19] A sedentary lifestyle and diet alterations (increased intake of total energy and saturated fat >10%-15% of total energy and decreased intake of fruits and vegetables) are major determinants of metS. 20 Diet is generally recognized to be significantly involved in changing the individual risk of developing VTE. [21] [22] [23] However, the involvement of diet-induced alterations in body weight and insulin sensitivity on ETP regulation has never been investigated and therefore needs clarification.
We aimed to evaluate the influence of diet on ETP in comparison with the influence of body weight and metabolic disturbances in both rats and humans. To study the respective role of changes in body weight, insulin sensitivity, and a direct effect of nutrients on ETP regulation, we studied in rats the effects of a high-fat (30%) diet given because weaning contrasted with controls or with rats programmed to develop metS. 24 We used an automated method already applied to rat plasma 25, 26 that allows a detailed kinetic analysis of whole ETP. Associations with body weight and metabolic and nutritional markers were assessed as well as ETP changes over time. ETP was evaluated in humans in relation to body weight, metabolic status, dietary composition, and plasma nutritional markers before and after switching from a Western diet to a 3-month recommended healthy diet.
Materials and Methods

Animals and Diets
All experimental procedures were approved by the local animal care and use committee. Wistar rats (Janvier, Le Genest St. Isle, France) were housed under standard conditions of light (12-hour light/dark cycle; lights on at 0600 hours) and temperature (22-24°C) , with free access to tap water and standard pellet diet (low-fat diet [LFD]) or high-fat diet (HFD).
Programming Procedure to Induce MetS
We have shown that postnatal overfeeding in rats, obtained by reducing the size of the litter in the immediate postnatal period, a time crucial for endocrine maturation, was followed in adulthood by a moderate overweight status, significant metabolic disturbances that exacerbated under HFD, comparable with those described in the metS. 24 At postnatal day 3, litters were culled to 10 newborns for normofed rats (control) or 3 pups for overfed rats (programmed). Male rats were weaned at postnatal day 21 
Time-Course Studies
Three-week-old control rats were fed with LFD or HFD and studied (n=6/group) after 2, 7, 28, or 70 days; 12-week-old control rats fed HFD from weaning were switched or not to LFD and studied after 2, 7, or 28 days (n=6/group). Lastly, 16-week-old control rats fed HFD from weaning (n=6) received subcutaneous injection of exenatide (20 mg/kg BW per day for 10 days; Byetta, Lilly Pharma, Giessen, Germany). Food intake and body weight were measured every other day.
Glucose Tolerance Test
Rats were fasted overnight and injected intraperitoneally with 1.5 mg/g d-glucose (30% stock solution). Blood samples were drawn under light Aerrane (2% in air; Baxter, Maurepas, France) anesthesia by tail venesection before, 30 minutes, and 120 minutes after the glucose load. Glucose was determined with the Accu-Chek performa meter and blood glucose test strips (Roche Diagnostics, Roche, Basel, Switzerland).
Blood Sampling
Overnight fasted rats were anesthetized with sodium pentobarbital (60 mg/kg BW; Ceva Santé Animale, Libourne, France) and subjected to portal vein puncture between 8 and 10 am. To avoid platelet activation, the syringe and the needle were precoated with a 3.2% trisodium citrate solution. Blood samples were drawn into vacutainer tubes containing 3.2% trisodium citrate solution (ratio 9:1; Becton Dickinson, Pont de Claix, France) for the coagulation test and the thrombin generation assay. Platelet-poor plasma was obtained after double centrifugation (3000g for 10 minutes at 25°C twice) and kept frozen at −80°C until analysis. Liver was dissected and weighed.
Laboratory Assays
Plasma insulin, adiponectin, and leptin levels were determined by radioimmunoassays (Millipore, Molsheim, France). Concentrations of total cholesterol and triglycerides were determined in diluted serum samples with the automated Cobas-Bio analyzer (Roche). To determine plasma fatty acids (FAs) composition, lipids were extracted from plasma according to the method described by Bligh and Dyer. 27 FA methyl esters were prepared and analyzed by gas chromatography on a Perkin-Elmer Autosystem XL equipped with a flame ionization detector. All hemostasis-related parameters were assayed using the STA-R automatic analyzer and commercially available kits and reagents from Stago (Asnières, France), including the corresponding normal and pathological control plasmas. Fibrinogen plasma levels were assayed using the STA-Fibrinogen kit (Clauss method), factor II (FII), factor V (FV), factor VII (FVII), factor VIII (FVIII), factor IX (FIX), and factor X (FX) procoagulant activities were determined using the corresponding STA-deficient plasmas. The antithrombin chromogenic antithrombin heparin cofactor activity (Stachrom ATIII, Stago) was measured using established commercial assays on STA-R evolution (Stago). F1+2 was assayed using a commercial ELISA assay (USCN Life Science Inc., Wuhan, China). Tissue factor (TF) pathway inhibitor, free protein S, and protein C were assayed using commercial ELISA assays (Stago).
Thrombin Generation Tests
To assess plasma thrombogenic potential in human and rat plasma, the thrombogram was analyzed using the calibrated automated thrombography (Thrombinoscope BV, Maastricht, the Netherlands) according to the manufacturer's instructions in the 96-well plate fluorometer (Ascent Reader, Thermolabsystems OY, Helsinki, Finland) equipped with the 390/460 filter and set at a temperature of 37°C. Eighty microliters of platelet-poor plasma was diluted with 20 µL of the reagent containing 5 pmol/L recombinant TF, 4 µmol/L of a mixture of phospholipids, and 20 µL of FluCa solution (0.1 mol/L CaCl 2 , 20 mmol/L HEPES, and 60 g/L bovine serum albumin), which contain the fluorescent substrate Z-Gly-Gly-Arg-amido metyl coumarin (2.5 mmol/L; Bachem). Only 1 batch of each reagent was used, and all plasma samples were tested the same day under the same conditions. Each plasma sample was analyzed in duplicate. We used Thrombinoscope software (Synapse BV) to convert the fluorescent signal to thrombin concentration by continuous comparison with the signal generated by a thrombin calibrator (Synpase BV) added to a separate sample of the test plasma. The thrombograms were analyzed for the following parameters: lag time, time to thrombin peak; peak height (indicative of maximal rate of thrombin formation); and area-under-the-curve or ETP, reflecting total activity of thrombin during coagulation. At 5 pmol/L TF, thrombin generation relies on the extrinsic coagulation pathway.
FV and FII Leiden Genotyping
To study diet efficiency on ETP in patients with genetic predisposition for VTE, genotyping for FV (rs6025) and FII Leiden (rs1799963) was performed by duplex allele-specific polymerase chain reaction. Reaction conditions and primers sequences are available on request.
Diet Intervention in Humans
ETP and coagulation factors were measured in 65 volunteers from the Mediterranean Diet, Cardiovascular Risks and Gene Polymorphisms study 28 before and after switching from a Western diet to a 3-month recommended healthy diet: either a Mediterranean-type diet or a LFD as prescribed by the American Heart Association diet. The Mediterranean-type diet recommended to eat nuts, olive oil, wholemeal bread, cereals, fruits and vegetables, fish (4 times/wk), poultry, and sheep meat and to reduce red meat consumption (once/wk). The American Heart Association diet recommended to eat vegetable oils, fruits and vegetables, low-fat dairy products, and fish (2-3 times/wk); to prefer poultry to mammal meat; and to avoid offal and saturated fat-rich animal products. The eligible subjects signed informed consent as approved by the institution's ethics committee. The citrated samples used in this study were stored at −80°C without thawing before this study. The protocols used for dietary assessment and calculation of nutrients intakes were previously detailed. 29 Because the 2 diets did not generate markedly different supplies of macro-and micronutrients, both populations were grouped all over the study. October 2012
Statistical Analysis
Results are expressed as mean±SE. All analyses were performed using GraphPad Prism (San Diego, CA) version 4.0 for Windows or StatView 5.0 (Abacus Concepts). All data were found to be normally distributed (Kolmogorov-Smirnov test). Differences between 2 groups were analyzed using the Student t test. When >2 groups were compared, 1-way ANOVA followed by the Bonferroni multiple comparison test or ANOVA for repeated measures was used. The Pearson correlation coefficient was used to examine the association between 2 variables. Multiple variables were analyzed by stepwise regression. Significance was set at P<0.05.
Results
Studies in Rats
Metabolic Phenotype of the Various Groups of Rats Table 1 shows the results of body weight and metabolic parameter measurements. In fasted adult animals, liver weight, glycemia, insulin, and lipids did not differ between groups. Compared with control LFD (CLFD) rats and programmed LFD rats, programmed HFD animals showed a significant increase in body weight (P<0.01). Homeostasis model assessment (HOMA) of insulin resistance was enhanced in programmed HFD rats when compared with CLFD and programmed LFD (P<0.05). Intraperitoneal glucose tolerance testing confirmed that highfat feeding in association with postnatal programming induced insulin resistance. Indeed, the area under the curve for plasma glucose and insulin increased in programmed HFD rats compared with CLFD and programmed LFD (P<0.05), indicating a failure to regulate blood glucose effectively.
HFD, but Not Programming or Insulin Resistance, Increased ETP ETP greatly differed between groups of rats. ETP was significantly increased after 16 weeks of HFD but was not altered by programming ( Figure 1A ). HFD accordingly increased the peak and velocity of thrombin generation significantly ( Table  I in the online-only Data Supplement). Remarkably, insulinresistant programmed HFD rats did not exhibit higher ETP than CHFD animals. ETP levels did not correlate with body weight, but instead showed a strong positive correlation with liver weight (r=0.51; P<0.0001; n=74). No link was found between ETP and indices of insulin resistance, plasma insulin area under the curve after a glucose load, or HOMA (r=0.22 and r=0.16, respectively; P>0.05; n=74). In contrast, ETP was associated with dyslipidemia (cholesterol: r=0.37; P<0.05; and triglycerides: r=0.36; P<0.05; n=43).
Nutritional and Hemostatic Determinants of ETP
The main changes in circulating FA composition are detailed in Table 1 . HFD was associated with a decrease in polyunsaturated fatty acid (PUFA) and an increase in monounsaturated FA, whereas the levels of total saturated fat did not change, reflecting the changes in diet composition (Table II in the onlineonly Data Supplement). ETP was strongly and negatively associated with omega-3 or -6 PUFA: docosahexaenoic acid (DHA, C22:6n-3), linoleic acid (C18:2n-6), alpha-linolenic acid (C18:3n-3), and palmitoleic acid (C16:1n-7; r=−0.64 to −0.59; P<0.0001). In addition, ETP was positively correlated with the levels of stearic acid (C18:0, r=0.36; P<0.01) and omega-9 monounsaturated FA oleic acids (C18:1n-9) and hypogeic acid (C16:1n-9; r=0. 57 and r=0. 44; P<0.0001 and P<0.001, respectively; Figure 1B-1E) . The coagulant activity of FVII levels significantly increased in rats fed HFD. Remarkably, FV and FVIII levels were elevated in programmed rats, irrespective of diet (Table 1) . ETP positively correlated with FVIIc (n=44, r=0.44; P<0.01, n=43) but did not significantly differ between the FVIIc quartiles ( Table 2) . It is thus obvious that FVIIc levels were only partially involved in ETP changes, indicating the contribution of other mechanisms. FVIIc was strongly and negatively associated with the PUFA and monounsaturated FA, linoleic acid, gamma-linolenic acid (C18:3n-6), palmitoleic acid, and nervonic acid (C24:1n-9; r=−0.57 to −0.30; P<0.05), but not with DHA levels. FVIIc did not correlate with the levels of stearic acid, although it did to a slight degree with oleic acid (r=0.36; P<0.05). In stepwise regression analysis including all correlates to ETP, only total PUFA related to ETP (Table 3) .
Standard Diet Reversed the Lactation-Induced ETP Increase
Immediately after weaning, 3-week-old control rats were fed with either LFD or HFD and euthanized 2, 7, 28, or 70 days later. At day 2, ETP values were increased in weaning CHFD rats when compared with adult CLFD rats (771±38 versus 648±34 nmol/L per minute; Student t test: P<0.05) and remained elevated throughout the experiment. Under LFD, ETP was not changed at day 7 (ANOVA for repeated measures: F=2.21, P=0.17) and showed a significant decrease (F=56.1, P<0.0001) starting at day 28, which plateaued until day 70 (Figure 2A ). In contrast, there was no difference in the growth rate between the 2 groups (F=0.884, P=0.46; Figure 2B ). Circulating insulin, adiponectin, leptin, and lipid levels followed a different kinetic than ETP. Insulin increased with age (F=38.1, P<0.0001) more rapidly in CLFD than in CHFD (F=7.64, P=0.0006; Figure 2C ). The increase in plasma leptin over time (F=12.1, P<0.0001) was comparable between groups (F=0.29, P=0.83; Figure 2D ). Adiponectin levels were diminished in CHFD compared with CLFD (F=42.0, P<0.0001) and decreased with age (F=42.3, P<0.0001) with a slower kinetic in CLFD compared with CHFD (F=8.78, P=0.0002; Figure 2E ). Cholesterol and triglycerides progressively decreased from weaning to day 70 (F=21.8 and F=23.0, respectively; P<0.0001) to the same extent in both groups (F=0.46, P=0.52 and F=1.35, P=0.29, in CLFD and CHFD, respectively; Figure 2F and 2G).
Switching From HFD to LFD Reversed the Procoagulant Phenotype Independent of the Metabolic Improvement
Control rats fed HFD for 12 weeks from weaning were switched or not to LFD. ETP was measured after 2, 7, and 28 days. A 1-week switch to LFD did not modify ETP (ANOVA for repeated measures: F=0.7, P=0.42), indicating a long-lasting effect of HFD. ETP reverted back to the values of rats fed LFD from weaning after 28 days (F=6.47, P=0.029; Figure  3A ). Body weight, leptin, and triglyceride levels did not differ between groups during the experimental period (F=0.3, P=0.59; F=0.21, P=0.66; F=2.34, P=0.17, respectively, Figure  3B , 3C, and 3E). In contrast, cholesterol levels decreased with time (F=6.0, P=0.01) to the same extent in both groups (F=0.38, P=0.55; Figure 3D ). Insulin levels decreased rapidly after the diet switch (F=8.26, P=0.016; Figure 3F ), reaching control values within 2 days, preceding ETP changes, whereas adiponectin levels increased after the diet switch (F=7.44, P=0.021; Figure  3G ). In keeping with the lack of correlation between metabolic status and ETP, exenatide treatment administered for 10 days in CHFD rats did not decrease ETP (700±31 versus 714±26 nmol/L per minute in untreated rats; P>0.05), although it significantly decreased body weight (533±19 versus 598±15 g in untreated rats; P<0.05) and tended to increase insulin levels (2.10±0.14 versus 1.63±0.15 ng/mL; P=0.06). Neither leptin nor adiponectin levels were altered by the treatment (not shown). 
Studies in Humans
P<0.01).
None of the hemostatic factors studied correlated with these nutritional markers. Only changes in the percentage of the protein:fat intake ratio, phenolic compounds, and FIX circulating levels related to ETP in stepwise regression analysis (Table 4 ; Figure I in the online-only Data Supplement).
Switching From Western Diet to Recommended Healthy Diet Reversed the Procoagulant Phenotype in Humans
Altogether the above data demonstrate the influence of diet composition on ETP in rats. We further examined whether diet modification could influence ETP in humans. Table 5 ETP indicates endogenous thrombin potential; CLFD, control low-fat diet; CHFD, control high-fat diet; PLFD, programmed low-fat diet; PHFD, programmed high-fat diet. provided by carbohydrates and proteins increased significantly (P<0.001 and P<0.05, respectively), whereas the percentage provided by total fat decreased (P<0.0003). The percentage of energy provided by saturated fat decreased over time, whereas that provided by polyunsaturated fat increased (P<0.001 and P<0.02, respectively). BMI, HOMA, low-density lipoprotein cholesterol, triglycerides, and apolipoproteins B and E were significantly lower after 3 months. Plasma FA concentrations of palmitic acid and palmitoleic acid significantly decreased, whereas those of eicosapentaenoic acid (C20:5n-3) and DHA significantly increased after 3 months. Interestingly, ETP significantly decreased by 21±2.8% after dietary intervention (P<0.0001; Table 6 ). This was associated with a parallel decrease in vitamin K-dependent factors (II, VII, IX, and X) and TF pathway inhibitor, whereas fibrinogen levels, cofactors V and VIII, antithrombin, free protein S, and protein C did not vary (Table 6 ). Decrease in ETP was not statistically different (P=0.12) after 3 months of Mediterranean-type diet (−25±4%, n=33) or American Heart Association diet (−18±5%, n=32). In contrast, diet did not influence F1+2 levels (5.83±0.12 versus 5.73±0.13 mg/mL before or after healthy diet, respectively; P=0.29). Diet-induced changes in ETP were also found in subjects with genetic risks factors for VTE. Subjects with FV Leiden or FII (G20210A) mutation showed diet-induced decrease in ETP (−22±9%; n=5).
Changes in ETP Inversely Correlated With Changes in Triglycerides and Eicosapentaenoic Acid and DHA Levels in Humans
Correlations between the intrasubject changes in ETP and the other parameters were based on pairwise analysis of the absolute changes from baseline during diet intervention. presents the univariate correlation coefficients (r values) for these changes between all pairs of nutritional biomarkers and hemostatic factors. The intrasubject changes in ETP were not associated with coagulation factor changes, but correlated strongly with the changes in nutritional biomarkers, mainly triglycerides and eicosapentaenoic acid (Table 7; Figure II in the online-only Data Supplement). Weaker positive correlations were also found between changes in ETP and changes in DHA, palmitoleic acid, and phenolic compound circulating concentrations, and the protein and carbohydrate intake levels. None of these nutritional changes correlated with changes in the coagulation parameters studied. They were weakly linked with distinct nutritional markers. Changes in FII were mainly associated with omega-6 PUFA and FIX with fiber intake, whereas those in FVII were associated with saturated FA levels. TF pathway inhibitor concentrations correlated negatively with triglycerides, protein intake, and phenolic compound levels but were independent of ETP. Only changes in the percentage of energy provided by proteins and DHA related to changes in ETP in stepwise regression analysis (Table 8) .
Discussion
The present study shows for the first time that diet strongly modulates ETP. HFD increased ETP in rats and a recommended healthy diet decreased ETP in humans, independent of body weight and insulin sensitivity. In addition, variations induced by diet on baseline ETP and intrasubject ETP changes were both strongly associated with markers of the nutritional status.
Our data show that HFD increased ETP, peak, and velocity of thrombin production in rats. As previously reported, postnatal programming accentuated metabolic disturbances induced by chronic high-fat feeding with higher body weight, glucose intolerance, and insulin resistance, 24 but it had no effect on ETP, because the high-fat feeding-induced increase in thrombin potential was comparable between controls and programmed animals. In addition, the changes in ETP caused by switching from HFD to LFD did not parallel changes in body weight, insulin, lipids, leptin, or adiponectin. Thus, it appears that changes in ETP were not a direct consequence of adipose tissue accumulation or of alterations of the circulating markers of glucose and lipid metabolism. In keeping with the above-mentioned observation, no association was found among BMI, metabolic status (HOMA, high-density lipoprotein, or dyslipidemia), and ETP in volunteers.
The diet-switch experiments among developing rat clearly underline the direct involvement of diet macronutrient composition. ETP values reverted back in CLFD rats 4 weeks after weaning, whereas ETP was still elevated in CHFD animals. This points out that a factor present in milk triggers ETP elevation. Indeed, fat provides 40% to 50% of the total calories in milk, which contains high concentrations of saturated (palmitic) and monounsaturated (oleic) fatty FA. These points argue that a link exists between diet composition and ETP. Remarkably, the diets enriched in fat (such as breast milk or the provided HFD) have a long-lasting effect, because 1 week of LFD was not sufficient to decrease the procoagulant phenotype observed in both postweaning and adult animals, although it was reversed after 4 weeks on LFD. A comparable phenomenon was also found in humans, as a 3-month period of a recommended healthy diet reversed the procoagulant phenotype with a 21% reduction of ETP. Interestingly, such phenomenon was also found in subjects with genetic risks factors for VTE. As expected, F1+2 levels were low in this population of normal volunteers and were not associated with ETP. Indeed, ETP reflects the whole potential of thrombin generation, whereas F1+2 corresponds to an actual surrogate of thrombin already generated in vivo. A 21% decrease in ETP can have important functional consequences. Indeed, we previously showed that quantitative antithrombin deficiency, a severe thrombophilia defect, caused a 33% increase in ETP when compared with family members without the deficiency. 30 Thus, our findings demonstrate that diet plays a pivotal role in regulating thrombosis potential. They strongly suggest that improving diet composition could be useful in primary prevention of VTE. In addition, ETP could represent an interesting tool to assess consequences of diet modifications or obesity medications on coagulation and on the subsequent risk of thrombosis.
The mechanisms involved in diet-induced ETP regulation are not clear. ETP changes were found to be nicely correlated with liver weight in rats and therefore may reflect HFDinduced liver alterations. Most of the coagulant factors are produced by the liver and some of them require vitamin K for optimal synthesis. Nonalcoholic fatty liver disease is closely related to metS and has been associated with increased levels 
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A proteomic analysis recently demonstrated key changes in protein expression between control subjects and patients with different stages of fatty liver, including an increase in fibrinogen and prothrombin levels. 32 Passaro and colleagues 33 have reported that, in women with a moderate risk for cardiovascular disease, in particular the existence of an inflammatory status (increase in C-reactive protein), a diet enriched in alcohol and antiinflammatory components was able to decrease both FVII and FVIII together with a prolongation of thrombin generation initiation and propagation time, but without any change in ETP. Typically, in our rat study, HFD increased only FVIIc, the first enzyme of the blood coagulation system that serves as a priming function for triggering the clotting cascade. Despite the association between FVIIc and ETP, elevation of FVIIc only partly explained ETP variations in rats, indicating the contribution of other mechanisms. The above-mentioned observation is consistent with earlier studies, which showed that changes in FVII are of little importance for coagulation potency. 34, 35 In contrast with FVIIc, the other factors did not change: FII, a well-known determinant of ETP, the other 2 vitamin K-dependent factors, FIX and FX, and fibrinogen were not found to be elevated. In the clinical study, we found that, under basal conditions, ETP was related to FII, FIX, and FX. Species differences may account for the above-mentioned discrepancy. Consistent with the lack of variation in fibrinogen levels, HFD did not modify FVIII levels, which rules out proposing an inflammatory state as a triggering mechanism. The antithrombin level also remained unchanged, suggesting that HFD leads to a hypercoagulable state in rat plasma by influencing thrombin formation rather than thrombin inactivation. Further experiments are clearly needed to elucidate the mechanisms by which the nutritional status regulates ETP in rats.
In humans, correlation analysis showed that coagulation factors were associated with ETP under basal conditions, supporting their involvement in intersubject ETP variations, as previously described. 4, 36 Switching from a Western diet to recommended healthy diet improved BMI and insulin sensitivity. Such parameters were not correlated with ETP. Elevated ETP was found in obese or overweight compared with lean children, 13, 14 and a reduction in ETP has been described 2 years after bariatric surgery. 12 However, the above-mentioned studies were performed in morbidly obese patients, and a possible role of nutritional factors has not been taken into account. It has been recently demonstrated in a large population of lean, overweight, and obese subjects that BMI was not independently associated with ETP. 37 In the present study, 16 patients of the 65 studied were either obese or insulin-resistant; 9 and 10 of them being still obese or insulin-resistant, respectively, after the healthy diet. Studies in obese patients with or without diabetes mellitus could be worth performing. Interestingly, stepwise regression analysis supported an independent contribution of the nutritional status to intrasubject ETP regulation. The protein:fat ratio and circulating polyphenol levels were independently and negatively associated with ETP. Such correlation could be subsequent to the beneficial effect of diets rich in fruits and vegetables (which contain substantial amounts of antioxidant compounds, such as polyphenols) 38 and low in less desirable components of animal origin (such as saturated fat). These data are in line with the Longitudinal Investigation of Thromboembolism Etiology study, which concluded that a diet including more plant food and fish and less red and processed meat is associated with a lower incidence of VTE. 39 In the present study, switching to healthy diet was followed by a decrease in coagulation factors, mainly FII and FVII. However, because of the small variations observed and the lack of correlation between coagulation factors and ETP, it is doubtful that changes in coagulation factors could account for changes in ETP, 40 corroborating our data in rats. Stepwise regression analysis underlined the independent effect of changes in the percentage of energy intake provided by proteins and by circulating DHA levels on ETP. Such association between PUFA and ETP is consistent with our findings in rats. The physiological relevance of omega-3 PUFA in ETP regulation may be explained by interference with the production of vitamin K-dependent coagulation factors 41, 42 or by other phenomena. 43, 44 Although diet composition was enriched in vitamin K-containing nutrients, the lack of change in protein C and free protein S after healthy diet strongly suggests that vitamin K was not involved in diet-induced ETP regulation. Such phenomenon could be a result of the reduction of fat intake, with a subsequent decrease in vitamin K bioavailability. In keeping with this, our study showed that intrasubject DHA variations were associated with changes in ETP, but not with variations in vitamin K-dependent factors. In humans, fish oil supplementation has been shown to decrease ETP weakly (2%) but significantly. 45 More recently, Gajos et al 46 found a 13.4% reduction in peak, but not in ETP, after 1 month of omega-3 PUFA administration, indicating that global healthy diet affected the procoagulant phenotype more efficiently than fish oil or PUFA supplementation.
In addition, FV and FVIII levels were found to be elevated in adult programmed rats independent of the HFD and were not affected by diet intervention in humans. The homologous proteins FV and FVIII are cofactors of coagulation. Their activity is generated after limited proteolysis. Once activated, FVa and FVIIIa have a tremendous influence on ETP. This finding indicates that modifications of the perinatal environment can affect the hemostatic balance in adulthood. Although programming did not change ETP, it would further strengthen the risks of thrombotic occlusion of a vessel after lesion of an atherosclerotic plaque.
In conclusion, our data show for the first time that global diet plays a pivotal role in regulating thrombosis potential in humans, strongly suggesting that dietary intervention could be useful in primary prevention of thrombosis. Thus, our observations urge the need for randomized controlled clinical trials to compare nutritional recommendations with standard strategy in patients at risk for VTE. 
